PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Imbruvica/Venclyxto tops Gazyva plus chemo in first-line CLL/SLL

Johnson & Johnson’s BTK inhibitor Imbruvica plus AbbVie and Roche’s Vencylxto demonstrated superiority over Gazyva plus chemotherapy in a new Phase III study. In...
Continue Reading →
News

AZ, Pfizer/BioNTech vaccines ‘highly effective’ against Delta variant

AstraZeneca and Pfizer/BioNTech’s COVID-19 vaccines are ‘highly effective’ at protecting against the Delta (previously known as the Indian) variant, according to new...
Continue Reading →
News

Novavax’s COVID-19 vaccine shows 90% efficacy in Phase III

Novavax has announced that its COVID-19 vaccine candidate, NVX-CoV2373, demonstrated 90.4% overall efficacy in a Phase III trial conducted across sites in the US and...
Continue Reading →
News

Aptar Pharma Names Nordic Semiconductor Key Supplier for Digital Healthcare Solutions Portfolio

Aptar Pharma, a leading supplier of drug delivery devices, components, active material solutions and services has named Nordic Semiconductor a key supplier for its d...
Continue Reading →
News

NICE recommends Tecentriq for first-line NSCLC

The UK National Institute for Health and Care Excellence (NICE) has recommended Roche’s Tecentriq (atezolizumab) monotherapy for untreated metastatic non-small cell ...
Continue Reading →
News

New research identifies single biomarker that can indicate underlying neurodegeneration

New research has identified a single biomarker that can be used to accurately identify underlying neurodegeneration among people with cognitive issues. The new study...
Continue Reading →
News

Momentous moment as FDA approves aducanumab as treatment for Alzheimer’s disease

The US Food and Drug Administration (FDA) has approved Aduhelm (aducanumab) to treat patients with Alzheimer’s disease using the accelerated approval&...
Continue Reading →
News

Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson’s disease

Bayer AG announced today that BlueRock Therapeutics (BlueRock), a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, successfully admi...
Continue Reading →
News

CDC COVID-19 study shows mRNA vaccines reduce risk of infection by 91 percent for fully vaccinated people

A new CDC study finds the mRNA COVID-19 vaccines authorized by the Food and Drug Administration (Pfizer-BioNTech and Moderna) reduce the risk of infection by 91 perc...
Continue Reading →
News

BSP PHARMACEUTICALS CONTINUES EXPANSIONS AND INVESTMENTS IN LATINA’S PLANT

BSP PHARMACEUTICALS, a CDMO TECHNOLOGICALLY DEVELOPED TO MEET THE NEEDS OF INNOVATORS, progress the MULTI­MILLION € INVESTMENTS TO ADD MANUFACTURING CAPACITY FOR...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026